factory customized 4-(4-Aminophenoxy)-N-Methyl-2-Pyridinecarboxamide - Remdesivir Intermediate CAS 946511-97-3 COVID-19 (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

"Based on domestic market and expand abroad business" is our progress strategy for Weight 127.18, CAS 161596-47-0, p-Anisic Acid CAS 100-09-4, Welcome any inquiry to our company. We will be glad to establish friendly business relationships with you!

factory customized 4-(4-Aminophenoxy)-N-Methyl-2-Pyridinecarboxamide - Remdesivir Intermediate CAS 946511-97-3 COVID-19 (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Commercial Supply Remdesivir and Related Intermediates

Chemical Name	(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride
Synonyms	Remdesivir Intermediate; L-Alanine 2-Ethylbutyl Ester Hydrochloride; Remdesivir Amino Ester Compound; Remdesivir Related Compound 8; Remdesivir Impurity 8
CAS Number	946511-97-3
CAT Number	RF-PI298
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C9H20ClNO2
Molecular Weight	209.71
Brand	Ruifu Chemical

Item	Specifications
Appearance	White to Almost White Powder
Loss on Drying	≤1.0%
Single Impurity	≤0.50%
Total Impurities	≤1.0%
Heavy Metals	≤20ppm
Purity	≥99.0%
Test Standard	Enterprise Standard
Usage	Intermediate of Remdesivir (CAS 1809249-37-3); COVID-19

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride (CAS 946511-97-3), it’s typically used for the preparation of Remdesivir (CAS 1809249-37-3). Remdesivir, also known as GS-5734, is a novel antiviral drug in the class of nucleotide analogs developed by Gilead Sciences, with effective antiviral activity( EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells). In February 2020 Remdesivir was being studied for experimental treatment of the emergent COVID-19 (novel coronavirus) disease.

Product detail pictures:

Related Product Guide:

Our well-equipped facilities and superb good quality control throughout all stages of manufacturing enables us to guarantee total buyer gratification for factory customized 4-(4-Aminophenoxy)-N-Methyl-2-Pyridinecarboxamide - Remdesivir Intermediate CAS 946511-97-3 COVID-19 (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride – Ruifu , The product will supply to all over the world, such as: Lesotho, Estonia, Surabaya, We have more than 100 works in the plant, and we also have a 15 guys work team to service our customers for before and after sales. Good quality is the key factor for the company to stand out from other competitors. Seeing is Believing, want more information? Just trial on its products!